ArticleFrontiers in oncology2023

The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer.

Maria Letizia Cataldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.